CN108271893A - Blood fat reducing tea - Google Patents
Blood fat reducing tea Download PDFInfo
- Publication number
- CN108271893A CN108271893A CN201810332334.7A CN201810332334A CN108271893A CN 108271893 A CN108271893 A CN 108271893A CN 201810332334 A CN201810332334 A CN 201810332334A CN 108271893 A CN108271893 A CN 108271893A
- Authority
- CN
- China
- Prior art keywords
- blood fat
- fat reducing
- parts
- reducing tea
- hawthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of blood fat reducing teas.The blood fat reducing tea, including the following ingredient counted in parts by weight：1.5 4 parts of hawthorn；0.5 2 parts of cassia seed；0.8 2.5 parts of gynostemma pentaphylla.Blood fat reducing tea provided by the invention, has no toxic side effect, and has the effect of good triglyceride reducing, cholesterol, while can improve the concentration of high-density lipoprotein, to reduce the incidence for the other diseases that hyperlipidemia causes.
Description
Technical field
The present invention relates to health tea technical field, more particularly to a kind of blood fat reducing tea.
Background technology
With the continuous improvement of people's living standards, the incidence of the diseases such as hypertension, hyperlipidemia obviously rises, it can be direct
Cause some diseases such as atherosclerosis, coronary heart disease, pancreatitis etc. for seriously endangering health, threatens the middle-aged and the old's
Health has caused the concern of the whole society.
Traditional Chinese medicine thinks, though cream ester is the nutriment of human body, intake is excessive and cream ester transfers, utilization, excretion
The factors such as not normal can be such that blood fat increases.And hyperlipidemia category " phlegm is turbid ", " hemostasis " range, the cause of disease include mainly：Diet loses
When, few dynamic, emotional stimulation is worn with age, quench one's thirst, the diseases such as oedema not more etc..Main component in blood fat is triglycerides and courage
Sterol, therefore, hyperlipidemia are mainly shown as that triglycerides and cholesterol concentration increase.
In the prior art, triglyceride reducing common drug is fenofibrate, and norcholesterol common drug is that Statins is (such as pungent
Cut down statin, Atorvastatin).However, body can be generated larger side effect, wherein fenofibrate by taking the above drug too much
Special major side effects are that the symptoms such as gastrointestinal discomfort, fash, sexual hypoesthesia, insomnia occur, and the major side effects of Statins are
Hepatic lesion influences health to a certain extent.
In consideration of it, it is necessary to provide a kind of drugs having no toxic side effect to reduce blood fat, human body blood fat is made to maintain normally
It is horizontal.
Invention content
The technical problem to be solved in the present invention is to provide a kind of blood fat reducing teas having no toxic side effect, and have good drop glycerine
The effect of three esters, cholesterol, while the concentration of high-density lipoprotein can be improved, to reduce the other diseases of hyperlipidemia initiation
Incidence.
To solve the above-mentioned problems, technical scheme is as follows：
A kind of blood fat reducing tea, including the following ingredient counted in parts by weight：
1.5-4 parts of hawthorn；
0.5-2 parts of cassia seed；
0.8-2.5 parts of gynostemma pentaphylla.
Preferably, including the following ingredient counted in parts by weight：
2 parts of hawthorn；
1 part of cassia seed；
1.5 parts of gynostemma pentaphylla.
Preferably, the blood fat reducing tea is packed using filter bag, boiling water Instant Drinks repeatedly.
Preferably, the preparation method of the blood fat reducing tea includes the following steps：
Hawthorn, cassia seed and gynostemma pentaphylla are drawn materials by proportion compatibility, it is small to dry 18-30 under the conditions of 60-70 DEG C respectively
When；
It crushes, mixing, is dispensed into filter bag by taking dose.
Preferably, the blood fat reducing tea is dispensed by 9 grams/bag.
Compared to the prior art, blood fat reducing tea provided by the invention, advantageous effect are：
One, according to theory of traditional Chinese medical science, the pathology such as hyperlipidemia and spleen deficiency phlegm product, phlegm-blood stasis delay, the deficiency of liver-yin and kidney-yin, stomach energy internal organs reality because
It is plain related.Blood fat reducing tea provided by the invention, drug of choice hawthorn, cassia seed and gynostemma pentaphylla compatibility, wherein hawthorn, acid is sweet, micro-
Temperature enters spleen, stomach, Liver Channel, has invigorating the spleen, digestion gathered food, scattered silt blood, the effect of controlling phlegm and retained fluid, effect is comprehensive；Gynostemma pentaphylla micro-sweet, it is cool in nature,
Return lung, spleen, kidney channel, there is the effect of enriching yin boost qi, strengthening the spleen and reducing phlegm；Cassia seed, it is sweet in flavor, it is bitter, it trembles with fear, it is micro- salty, have and clears liver and improve vision, moistens
Intestines defaecation, clear the effect of rushing down stomach energy.In the compatibility, hawthorn is monarch drug in a prescription, and gynostemma pentaphylla and cassia seed are altogether ministerial drug, are had to hyperlipidemia
Apparent therapeutic effect can not only reduce the concentration of the blood fat main component such as triglycerides, cholesterol, can also improve high density
The concentration of lipoprotein, so as to treat and prevent other illnesss associated with hyperlipidemia.
Two, blood fat reducing tea provided by the invention, each ingredient is integration of drinking and medicinal herbs substance in compatibility, takes nonhazardous for a long time
Effect.
Specific implementation mode
In order to make those skilled in the art more fully understand the technical solution in the embodiment of the present invention, and make the present invention's
Above objects, features, and advantages can be more obvious and easy to understand, is further described below to the specific implementation mode of the present invention.
It should be noted that being used to help understand the present invention for the explanation of these embodiments, but do not constitute
Limitation of the invention.
Embodiment 1
Blood fat reducing tea, including the following ingredient counted in parts by weight：
2 parts of hawthorn；
1 part of cassia seed；
1.5 parts of gynostemma pentaphylla.
The blood fat reducing tea of the present embodiment is packed using filter bag, and Instant Drinks use boiling water repeatedly.
The preparation method of the blood fat reducing tea of the present embodiment includes the following steps：
Step S1：Hawthorn, cassia seed and gynostemma pentaphylla are drawn materials by proportion compatibility, dry 18- under the conditions of 60-70 DEG C respectively
30 hours；
Step S2：It crushes, mixing, is dispensed into filter bag by taking dose.
Embodiment 2
Blood fat reducing tea, including the following ingredient counted in parts by weight：
1.5 parts of hawthorn；
0.5 part of cassia seed；
0.8 part of gynostemma pentaphylla.
The blood fat reducing tea of the present embodiment is prepared using the preparation method of embodiment 1.
Embodiment 3
Blood fat reducing tea, including the following ingredient counted in parts by weight：
4 parts of hawthorn；
2 parts of cassia seed；
2.5 parts of gynostemma pentaphylla.
The blood fat reducing tea of the present embodiment is prepared using the preparation method of embodiment 1.
Embodiment 4
Blood fat reducing tea, including the following ingredient counted in parts by weight：
3 parts of hawthorn；
1.5 parts of cassia seed；
2 parts of gynostemma pentaphylla.
The blood fat reducing tea of the present embodiment is prepared using the preparation method of embodiment 1.
It should be noted that in addition to using filter bag packaging use, blood fat reducing tea provided by the invention can also use it
Three kinds, be such as divided into after being mixed by proportion compatibility and be directly brewed for quoting by his mode.
In order to illustrate the therapeutic effect of blood fat reducing tea provided by the invention, pharmacological evaluation and clinical examination are carried out individually below
It tests.
Pharmacological evaluation
1, test material：
A, high lipid food：
Including following ingredient by weight percentage：Normal diet 77.5%, lard 10%, cholesterol 2%, No. three courages
Salt 0.5%, yolk powder 10%；
B, fat decreasing tea：By taking the blood fat reducing tea that embodiment 1 provides as an example, tea product are packed with filter bag, 9 grams every bag；
2 bags of tea bag is taken, is added in 400ml, 100 DEG C of distilled water and impregnates, and be placed under 20 DEG C of room temperature environments, tea juice is collected after 2h.
2, modeling
After 60 SD male rat adaptable feds 7d, randomly selects 15 and be only used as blank control group and give common feeding
Material, remaining rat are divided into 3 groups after giving high lipid food reconstructed model 3 weeks, respectively：High in fat group, simvastatin group, fat decreasing tea
Group.
3, it is administered
Normal group, model group rats gavage give the distilled water of equal volume, and Simvastatin group rat gives 4mg/
Kg Simvastatin gavages, fat decreasing tea group rat give 10ml/kg blood fat reducing tea gavages.
4, it detects
Animal continues to give high fat diet in the administration stage, and 2,4, the 8 weekends fasting 12h after administration, eyeground vein clump takes
Blood system carries out lipids detection from serum and takes testing result such as table 1：
1 each group rat different time points blood fat situation of table compares (mmol/L)
* relatively there is significant difference (P with blank group<0.05), # relatively has significant difference (P with high in fat group<0.05).
By above-mentioned test data analyzer it is found that blood fat reducing tea provided by the invention can reduce hyperlipidemia rats TG,
TC, LDL-c concentration, and the HDL-c concentration of rat can be improved.The lipid-lowering effect of blood fat reducing tea provided by the invention and tradition drop blood
Fat drug Simvastatin compares no notable difference, but after long-term use, and blood fat reducing tea provided by the invention is improving HDL-c
There is advantage more more obvious than Simvastatin in terms of concentration.
Clinical test
Equally by taking the blood fat reducing tea that embodiment 1 provides as an example, clinical test is carried out.The method of clinical test：By tea product with
Filter bag is packed, repeatedly boiling water Instant Drinks, is warmly taken, daily one bag, 9 grams every bag；Select 30 hyperlipidemia patients, clinic examination
Test result data such as table 2：
The clinical testing data of 2 blood fat reducing tea of table
It should be noted that efficacy determination reference《New Chinese medicine guideline of clinical investigations》In related hyperlipidemia treat
Criterion is imitated to formulate.It is effective：Triglycerides (TG) declines >=40%；Effectively：TG declines >=20% but ＜ 40%；In vain：Blood
Fat detection is not up to the above standard person.
It can be seen that in 30 patients according to above-mentioned clinical testing data, effective 24, effective 5, invalid 1.Through dividing
Analysis can obtain, using blood fat reducing tea provided by the invention, obvious effective rate is up to 80%.
To sum up, blood fat reducing tea provided by the invention can not only reduce the dense of the blood fat main component such as triglycerides, cholesterol
Degree, can also improve the concentration of high-density lipoprotein, so as to treat and prevent other diseases associated with hyperlipidemia.Together
When, the blood fat reducing tea of offer of the invention, each ingredient in compatibility is the substance of integration of drinking and medicinal herbs, takes nontoxic secondary make for a long time
With.
Embodiments of the present invention are explained in detail above, but the present invention is not limited to described embodiment.
To those skilled in the art, these embodiments are carried out without departing from the principles and spirit of the present invention more
Kind change, modification, replacement and modification are still fallen within protection scope of the present invention.
Claims (5)
1. a kind of blood fat reducing tea, which is characterized in that include the following ingredient counted in parts by weight：
1.5-4 parts of hawthorn；
0.5-2 parts of cassia seed；
0.8-2.5 parts of gynostemma pentaphylla.
2. blood fat reducing tea according to claim 1, which is characterized in that include the following ingredient counted in parts by weight：
2 parts of hawthorn；
1 part of cassia seed；
1.5 parts of gynostemma pentaphylla.
3. blood fat reducing tea according to claim 1, which is characterized in that the blood fat reducing tea is packed using filter bag, boiling water
Instant Drinks repeatedly.
4. blood fat reducing tea according to claim 1, which is characterized in that the preparation method of the blood fat reducing tea includes following step
Suddenly：
Hawthorn, cassia seed and gynostemma pentaphylla are drawn materials by proportion compatibility, dried 18-30 hours under the conditions of 60-70 DEG C respectively；
It crushes, mixing, is dispensed into filter bag by taking dose.
5. blood fat reducing tea according to claim 4, which is characterized in that the blood fat reducing tea is dispensed by 9 grams/bag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810332334.7A CN108271893A (en) | 2018-04-13 | 2018-04-13 | Blood fat reducing tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810332334.7A CN108271893A (en) | 2018-04-13 | 2018-04-13 | Blood fat reducing tea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108271893A true CN108271893A (en) | 2018-07-13 |
Family
ID=62811422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810332334.7A Pending CN108271893A (en) | 2018-04-13 | 2018-04-13 | Blood fat reducing tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108271893A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109350659A (en) * | 2018-12-10 | 2019-02-19 | 成都大学 | A kind of blood lipid-reducing blood sugar-decreasing composition and preparation method thereof, application |
| CN112913947A (en) * | 2021-04-15 | 2021-06-08 | 王晓军 | Gynostemma pentaphylla lipid-lowering tea |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106728108A (en) * | 2017-02-17 | 2017-05-31 | 福建康是美生物科技有限公司 | A kind of hypertension and hyperlipemia Chinese medicine composition containing gynostemma pentaphylla |
-
2018
- 2018-04-13 CN CN201810332334.7A patent/CN108271893A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106728108A (en) * | 2017-02-17 | 2017-05-31 | 福建康是美生物科技有限公司 | A kind of hypertension and hyperlipemia Chinese medicine composition containing gynostemma pentaphylla |
Non-Patent Citations (2)
| Title |
|---|
| 吴德峰: "《实用中草药》", 31 October 2017, 上海科学技术出版社 * |
| 李睿: "《第一次泡药茶就上手》", 30 November 2016, 哈尔滨出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109350659A (en) * | 2018-12-10 | 2019-02-19 | 成都大学 | A kind of blood lipid-reducing blood sugar-decreasing composition and preparation method thereof, application |
| CN109350659B (en) * | 2018-12-10 | 2021-09-14 | 成都大学 | Lipid-lowering and blood-sugar-reducing composition, and preparation method and application thereof |
| CN112913947A (en) * | 2021-04-15 | 2021-06-08 | 王晓军 | Gynostemma pentaphylla lipid-lowering tea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101822749B (en) | Medicinal preparation for curing hypertension and hyperlipaemia and preparation method thereof | |
| JP2020172523A (en) | Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system | |
| CN112426494A (en) | Composition, preparation method and application thereof | |
| CN105998093A (en) | Blood-glucose-lowering ganoderma lucidum instant micro-encapsulated preparation and preparation method thereof | |
| CN108271893A (en) | Blood fat reducing tea | |
| CN1558768A (en) | A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof | |
| CN104306554B (en) | A kind of food, health products or pharmaceutical composition for treating gastric ulcer | |
| CN106236927A (en) | A kind of Chinese medicine composition with enhancing immunity and antifatigue effect and preparation method thereof and purposes | |
| CN102068557B (en) | Application of Pu'er tea extract in preparation of medicines for reducing blood fat | |
| CN103230486B (en) | Traditional Chinese medicine composition, preparation method thereof, and application thereof in preparing medicines used for treating fatty liver | |
| CN109125315A (en) | Composition and purposes with hypoglycemic, reducing blood lipid and hypotensive activity | |
| CN102423382A (en) | Traditional Chinese medicine composition for treating dyslipidemia and application thereof | |
| CN106173605A (en) | A kind of Hyperglycemic health care compositions comprising Radix Puerariae and Herba Dendrobii | |
| CN107412713A (en) | Treat Chinese patent drug, dietetic food and the preparation method of autoimmune and immune related diseases | |
| CN105101817B (en) | Edible composition and preparation method thereof and the food comprising said composition | |
| CN110051817A (en) | A kind of Chinese traditional medicine composition and its application reducing uric acid | |
| CN108498568A (en) | Chinese patent drug, medical food and the preparation method of autoimmune and immune related diseases are treated with Goat Placenta or embryo | |
| CN108420890A (en) | A kind of composition and preparation method thereof with effect for reducing blood fat | |
| CN104623097A (en) | Application of Pu'er tea extract in preparation of fat reducing medicines or health foods | |
| CN106174193A (en) | A kind of health-care food composition of auxiliary blood fat reducing containing Armeniaca mume Sieb. and preparation method thereof | |
| CN112791140A (en) | Composition and application thereof in protecting liver and reducing blood fat | |
| CN111000949A (en) | Composition for improving subcutaneous fat type obesity and preparation method thereof | |
| CN106177476A (en) | A kind of Hyperglycemic health care compositions comprising Herba Dendrobii and Pericarpium Citri Reticulatae | |
| CN108968066A (en) | A kind of ginseng of strengthen immunity, Rhizoma Atractylodis Macrocephalae, Poria cocos, herbal cuisine element product of fructus lycii and preparation method thereof | |
| CN106581142A (en) | Compound traditional Chinese medicine composition capable of regulating blood fat and purpose thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180713 |
|
| RJ01 | Rejection of invention patent application after publication |